I nflammatory activation of ECs influences atherosclerosis, a chronic inflammatory disease of arteries, by promoting the recruitment of mononuclear cells from the circulation to the vessel wall. [1] [2] [3] Atherosclerosis occurs at distinct sites of the arterial tree located near branches and bends (eg, inner curvature of aortic arch). 4 These regions are susceptible to lesion formation, in part, because ECs at these areas are activated and therefore primed for leukocyte recruitment. 4 -12 Several lines of evidence suggest that the spatial distribution of lesions is governed by shear stress (the frictional force exerted on ECs by flowing blood), which varies in time, magnitude and direction according to vascular pulsatility and geometry. First, activation of EC and lesion formation occurs preferentially at regions of arteries exposed to low/oscillatory shear stress, whereas regions exposed to high, unidirectional shear are protected. [13] [14] [15] Second, a causal relationship between shear stress and atherosclerosis was established by Cheng et al 16 who used a flow-altering device (constrictive cuff) that reduced shear stress and generated oscillations of the shear stress field in carotid arteries of an atherosusceptible strain of mice. Third, ECs detect shear stress via mechanosignaling complexes 17 that transduce biochemical signals that influence proinflammatory activation. 9,10,13,18 -20 Nuclear factor (NF)-B transcription factors promote vascular inflammation by inducing adhesion proteins and other proinflammatory molecules in vascular ECs. 21, 22 The most abundant form of NF-B in ECs, the RelA/p50 heterodimer, is sequestered in the cytoplasm of unstimulated cells through binding to inhibitory IB molecules. Signaling to NF-B proceeds via distinct pathways that converge to destabilize IB, 21, 22 thus releasing NF-B for nuclear translocation and transcriptional activation. Despite numerous detailed studies of the signaling pathways that promote nuclear translocation and activation of NF-B, 21 the factors that regulate the expression levels of NF-B subunits and the physiological importance of differential NF-B expression have received little attention. Here we describe the first example of a signaling pathway that controls RelA NF-B subunit expression. Specifically, RelA is positively regulated by JNK1, a mitogen-activated protein (MAP) kinase, 23 and the downstream transcription factor ATF2. This pathway was stimulated in ECs by low or low/oscillatory shear stress and it enhanced expression of RelA and promoted inflammation at atherosusceptible sites. Thus we suggest that crosstalk between the JNK and NF-B signaling pathways may influence the spatial distribution of atherosclerotic lesions.
Methods

Cuff Placement
Constrictive cuffs with an internal diameter of 500 m tapering to 250 m over 1 mm or nonconstrictive cuffs (internal diameter 600 m) were placed on the right carotid artery of isoflurane-anesthetized mice following published methods. 16 
Transfection
Cell cultures that were 80% to 90% confluent were transfected with small interfering (si)RNAs (or with nontargeting scrambled controls) by microporation (Digital BioTechnology, Seoul, Korea) following the instructions of the manufacturer.
Comparative Real-Time PCR
Transcript levels were quantified by comparative real-time PCR as described previously. 18 
Western Blotting
Total cell lysates were prepared using a kit (Active Motif). Western blotting was carried out using specific primary antibodies, horse radish peroxidase-conjugated secondary antibodies and chemiluminescent detection.
Assay of NF-B DNA Binding
Binding of RelA NF-B subunits to consensus oligonucleotides was assessed by DNA-binding ELISA (Active Motif) using total cell lysates that were prepared using a kit (Active Motif). Chromatin immunoprecipitation was carried out using either anti-ATF2 antibodies or isotype-matched IgG control antibodies as described previously. 24 Precipitation of specific genomic DNA fragments was assessed by real-time PCR.
Studies of Murine Arteries
The expression levels of specific proteins were assessed in ECs at regions of the inner curvature (susceptible site) and outer curvature (protected site) of murine aortae by en face staining as described. 7,9 -11 In vivo 18 F-fluorodeoxyglucose positron emission tomography/computed tomography imaging was carried out using a combined PET/CT preclinical scanner as described. 25 CT, PET and CT angiography data were coregistered and standardized uptake values normalized to body weight were calculated for regions of interest.
Statistics
Differences between samples were analyzed using an unpaired or paired Student t test or 1-way ANOVA with Bonferroni adjustment.
Results
JNK1-ATF2 Signaling Positively Regulates RelA Expression
We previously identified transcriptional programs regulated by JNK using a microarray-based approach to study human umbilical vein ECs (HUVECs) treated with a pharmacological JNK inhibitor (CT536706). 11 Further analysis of these data revealed that treatment with CT536706 reduced the basal expression of components of the NF-B signaling pathway including RelA (downregulated 1.6 fold). We validated this observation by independent experiments which confirmed that pharmacological inhibition of JNK using either CT536706 or SP600125 led to reduced basal expression of RelA at both mRNA ( Figure 1A ) and protein ( Figure 1B ) levels. Further validation was obtained using JNK1-specific siRNA which suppressed the expression of JNK1 (without altering ATF2 expression) and significantly reduced the expression of RelA, whereas a scrambled, nontargeting control had no effect ( Figure 1C) .
We subsequently examined whether JNK influences RelA expression by activating the downstream transcription factors ATF2 or c-Jun. Immunofluorescent staining revealed that activation of ATF2 by phosphorylation occurred constitutively in unstimulated cells ( Figure 1E, top) . Silencing of ATF2 led to a significant reduction of RelA at both the mRNA ( Figure 1D ) and protein ( Figure 1E , bottom) levels, whereas silencing of c-Jun did not influence RelA expression ( Figure I , available in the Online Data Supplement at http://circres.ahajournals.org). Our data therefore indicate that RelA expression in ECs is positively regulated by JNK-ATF2 signaling, thus revealing crosstalk between the MAP kinase and NF-B signaling pathways.
We hypothesized that ATF2 may directly regulate the expression of RelA by binding to its promoter. To address this, we firstly carried out sequence alignment of RelA genes in multiple species to identify conserved sequences in the 5Ј untranslated region that may promote RelA expression. This Mean values(ϮSEM) were calculated from data pooled from 4 independent experiments. B, RelA protein levels were assessed by Western blotting (top), followed by densitometry and were normalized by measuring tubulin protein levels. Mean values(ϮSEM) were calculated from data pooled from three independent experiments (bottom). C and D, HUVECs were treated with JNK1-specific siRNA, ATF2-specific siRNA, or a scrambled, nontargeting sequence and were incubated for 48 hours. JNK1, ATF2, and RelA transcript levels were quantified by real-time PCR. Mean values(ϮSEM) were calculated from data pooled from 6 independent experiments. E, HUVECs were treated with ATF2-specific siRNA or with a scrambled, nontargeting sequence and were incubated for 48 hours. Fixed cells were assessed by immunofluorescence staining using anti-RelA conjugated to Alexafluor488 (green) and anti-phosphorylated ATF2 (red) antibodies. Cell nuclei were identified using ToPro3 (purple). Representative images are shown. RelA protein levels were quantified using image analysis software and are presented as mean values(ϮSEM). F and G, Binding of ATF2 to the 5Ј untranslated region of the RelA gene was assessed by ChIP. F, Nuclear lysates prepared from HUVECs were incubated with anti-ATF2 or irrelevant isotypecontrol antibodies before precipitation. The levels of RelA promoter DNA or an irrelevant sequence (GAPDH coding sequence) in precipitates and in nonprecipitated lysates (input) were assessed by comparative real-time PCR. The proportion of RelA promoter sequence that was precipitated from the starting material was calculated (% input) and mean levels(ϮSEM) are shown. G, HUVECs were exposed to CT536706 (2 mol/L) for 16 hours or were treated with vehicle alone. Nuclear lysates prepared from HUVECs were incubated with anti-ATF2 antibodies before precipitation and quantitation of RelA gene DNA levels in precipitates and input material as above. The proportion of RelA promoter sequence that was precipitated from the starting material was calculated (% input) and mean levels(ϮSEM) were calculated from 3 independent experiments.
bodies ( Figure 1G ), indicating that JNK positively regulates RelA expression by promoting binding of ATF2 to the RelA promoter.
JNK Primes ECs for Inflammatory Activation by Enhancing RelA Expression
Previous studies revealed that JNK acts as a positive regulator of inflammatory activation in cultured ECs. 26, 27 To assess whether JNK can prime cells for enhanced NF-B activation, we examined whether inhibition of JNK can influence the capacity of NF-B to bind consensus DNA sequences. Analysis of total lysates revealed that RelA-DNA binding in response to TNF␣ was reduced in cells pretreated with CT536706 ( Figure 2 ) or SP600125 (data not shown) compared to cells pretreated with vehicle alone.
JNK1 Enhances NF-B Expression and Promotes Inflammation at an Atherosusceptible Site in the Murine Aorta
We previously demonstrated that JNK1 is activated constitutively in ECs at a region of the murine aorta that is susceptible to inflammation and atherosclerosis (ie, the inner curvature of the aortic arch), whereas JNK1 activation is suppressed at a region that is resistant to atherosclerosis (ie, the outer curvature of the arch). 9 Given our observation that RelA is positively regulated by JNK1, we predicted that RelA and its target gene VCAM-1 will be expressed preferentially at atherosusceptible sites via a JNK1-dependent mechanism. Consistent with this hypothesis, en face staining studies of wild-type mice revealed that ECs at the susceptible site express higher levels of RelA protein (Figure 3 , compare images 1 and 2) and mRNA (Online Figure III) compared to ECs in the protected site. Moreover, the proportion of RelA that localized to the nucleus (an indicator of NF-B activation) was greater in ECs at the susceptible site compared to the protected site (Online Figure IV, A) . Elevated expression and nuclear localization of RelA at the susceptible site in wild-type mice correlated with expression of VCAM-1 and the accumulation of CD68-positive macrophages, whereas VCAM-1 expression was lower and macrophages were not observed at the atheroprotected site (Figure 3 
Low and Low/Oscillatory Shear Stress Enhances RelA Expression by Activating JNK
Atherosusceptible regions of arteries are associated with disturbed patterns of blood flow which exert low and/or oscillatory shear stress fields on ECs. Given that JNK1 activation 9 and RelA expression ( Figure 3) were observed preferentially at an atherosusceptible site, it is plausible that RelA expression may be regulated by shear stress via a JNK1-dependent mechanism. To test this hypothesis, we altered flow in the murine carotid artery by placing a constrictive cuff which causes tapering of the vessel lumen to generate high shear stress at the stenosis, a low shear environment upstream of the cuff and a low/oscillatory shear stress field downstream. 16 We observed using wild-type mice that exposure of ECs to low or low/oscillatory shear stress for 7 days led to enhanced activation of JNK ( shear stress influences ATF2 activity and RelA expression via a JNK1-dependent mechanism. Interestingly, although both flow patterns induced RelA to a similar extent, the application of low/oscillatory shear stress induced nuclear localization of RelA (a measure of NF-B activity; Online Figure IV , B) and VCAM-1 expression (Online Figure VI) to a greater extent than the application of low shear stress. These data suggest that a low/oscillatory shear stress environment may exert particularly proinflammatory effects on ECs by promoting JNK1-dependent expression and subsequent activation of NF-B. To assess whether vascular physiological changes occurred as a direct response to the altered mechanical environment we studied endothelial cells following the application of low or low/oscillatory shear stress for a relatively short period. We observed that cuff placement for 2 days enhanced the expression of RelA (Online Figure VII) and VCAM-1 (Online Figure VIII) through a JNK-1 dependent mechanism which is consistent with a direct response to altered shear stress.
Low/Oscillatory Shear Stress Promotes Inflammation by Activating JNK1
We examined whether induction and activation of RelA by placement of a constrictive cuff can initiate inflammation in carotid arteries using PET-imaging of 18 F-fluorodeoxyglucose (FDG) uptake, an indicator of metabolic activity that correlates with vascular inflammation. 28, 29 The role of JNK1 was determined by comparing FDG uptake in wild-type and JNK1
Ϫ/Ϫ animals. The potential effects of surgery and cuff placement per se were assessed by measuring FDG uptake in arteries modified with nonconstrictive cuffs that did not influence blood flow. FDG uptake from the contralateral side (control side opposite to the cuff) was similar for all groups (0.79Ϯ0.02; 1.07Ϯ0.21 and 0.99Ϯ0.01 g/mL for wild type with constrictive cuff, JNK1
Ϫ/Ϫ with constrictive cuff and wild type with nonconstrictive cuff respectively). Therefore, we expressed the data as the ratio between ipsi (cuffed artery) and contralateral uptake.
We observed that FDG uptake from the ipsilateral side was significantly higher at the site exposed to low/oscillatory shear stress (distal to the constrictive cuff) compared to sites exposed to either low (proximal to the constrictive cuff) or high shear stress ( Figure 5 , top left images). We concluded that FDG uptake was elevated as a response to altered hemodynamics and not as a consequence of the surgical procedure per se because application of a control, nonconstrictive cuff did not induce a similar relative increase in uptake in the distal region ( Figure 5 , lower left images). En face immunostaining revealed that exposure of arteries to low/oscillatory shear stress promoted the accumulation of intimal CD68-positive macrophages, which were observed at a relatively low frequency following 2 days exposure (Online Figure VII) and at a significantly higher frequency following 7 days (Figure 6 ; PϽ0.05). By contrast, CD68-positive cells were not observed at sites exposed to low or high shear for either 2 or 14 days (Online Figure VII; Figure 6 ). We observed by PET and immunostaining that genetic deletion of JNK1 reduced FDG uptake ( Figure 5 , top right images) and accumulation of macrophages ( Figure 6 , compare images 1 and 4) in the region exposed to low/oscillatory shear stress, indicating that JNK1 is required for inflammation at this site. Collectively, our in vivo studies demonstrate that JNK1 positively regulates endothelial NF-B expression and inflammation at regions of arteries exposed to disturbed flow.
Discussion
The NF-B and MAP kinase signaling pathways are regulated through multiple mechanisms that involve crosstalk at Ϫ/Ϫ mice (nϭ5 per group). After 14 days, the spatial distribution of 18 F-FDG uptake was studied in ipsi (experimental) and contralateral (unmanipulated) arteries by PET/CT. Positron emission data and CT angiography images were overlaid and representative images are shown. Each PET image was scaled from 0.5 to 3 standardized uptake values (g/mL). Positron emission was quantified at regions located either proximal (P) or distal (D) to the cuff and normalized to the uptake values obtained from the contralateral carotid artery. Mean ratios of FDG uptake(ϮSEM) are shown.
several different levels. For example, NF-B induces several negative regulators of MAP kinases which regulate the kinetics of JNK and p38 activation. 30 -32 Here we identify a novel mode of cross talk between these pathways where JNK pathway activation leads to elevated expression of RelA. Although it is established that c-Rel NF-B subunits are regulated at the expression level, 33, 34 few studies have suggested that RelA expression can be altered by physiological stimuli. [35] [36] [37] Thus our observations may be of fundamental importance because they indicate that RelA is regulated at the level of expression as well as at post-translational levels.
We suggest that the JNK-ATF2-NF-B signaling pathway that we described promotes inflammatory activation. This novel observation is consistent with previous studies demonstrating that VCAM-1 expression is positively regulated by both NF-B and AP-1 family transcription factors. 38, 39 Thus JNK-ATF2 signaling may regulate VCAM-1 expression through two parallel pathways -a direct route involving ATF2 interaction with the VCAM-1 promoter 38 and an indirect route involving ATF2-dependent induction of RelA for subsequent VCAM-1 promoter interaction. Aside from its importance in regulating inflammatory activation, JNK-ATF2 signaling may also prime cells for expression of other NF-B target genes that regulate diverse physiological processes. Although we focused on JNK1 because previous studies revealed that this isoform positively regulates endothelial activation and apoptosis, 26, 27, 11 we cannot rule out a potential role for other JNK isoforms in the regulation of NF-B.
We validated our in vitro findings by demonstrating that JNK positively regulates NF-B expression and promotes inflammation in murine arteries. Previous studies have revealed that the morphological and physiological properties of ECs differ greatly between atheroprotected and atherosusceptible sites. 4 -11,40 ECs at atherosusceptible sites express relatively high levels of NF-B proteins and are primed for inflammation, whereas ECs at protected sites express low amounts of NF-B and are resistant to inflammation. [5] [6] [7] 12 Here we reveal that the molecular mechanism underlying the distinct spatial distribution of NF-B expression involves JNK1 signaling which enhances NF-B expression at atherosusceptible sites but not protected sites.
Spatial variation in EC morphology and physiology has been attributed to spatial variation in hemodynamics. Atheroprotected sites are exposed to high rates of unidirectional flow whereas atherosusceptible sites are exposed to lower rates of disturbed patterns of flow. 4, [13] [14] [15] 41 Here we investigated the influence of blood flow on EC physiology by applying a flow-altering constrictive cuff which generates two different forms of atherosusceptible blood flow -a low shear environment and a low/oscillatory shear environment. 16 Our studies of cuffed arteries revealed that both low/oscillatory and low shear stress induced RelA expression via JNK1. It is unlikely that the underlying mechanism involves the recruitment of CD68-positive inflammatory cells as they were not observed at the low shear region and were infrequent at the low/oscillatory shear site (at 2 days following cuff placement). It is plausible that atherosusceptible blood flow induces RelA expression via shear stress-mediated activation of mechanosignaling complexes, however we cannot rule out other possibilities eg, alterations in mass transport. 41 Interestingly, we observed that activation of NF-B and expression of VCAM-1 was enhanced at the low/oscillatory shear region compared to the low shear site, and that inflammation occurred exclusively at the low/oscillatory shear region. These data suggest that low and oscillatory forces have differential effects on EC activation and vascular inflammation. Specifically, low shear may prime ECs for inflammatory activation by inducing NF-B expression, whereas oscillatory shear promoted both expression and nuclear localization (activation) of NF-B which subsequently promotes inflammation. At a broader level, our observation that different forms of atherosusceptible blood flow have specific effects on EC physiology reinforces the concept that heterogeneity in EC phenotypes may arise because of local differences in the magnitude or direction of shear forces that they are exposed to. 5, 40 Our observation that low/oscillatory shear can promote vascular inflammation in normocholesterolemic conditions is consistent with previous reports of low-grade inflammation at atherosusceptible sites in wild-type mice. 12 It suggests that low/oscillatory shear stress may promote early atherogenesis by enhancing the accumulation of macrophages/ dendritic cells at branches and bends 12, 42 However, a previous study revealed that low/oscillatory shear stress promoted the formation of stable type lesions that contained few inflammatory cells in hypercholesterolemic ApoE Ϫ/Ϫ mice, 16 suggesting that low/oscillatory shear stress may have differential effects on vascular inflammation during plaque initiation and progression.
PET imaging of cuffed arteries allowed us to assess the effects of altered blood flow on vascular function in living animals. In preliminary studies, we attempted to assess FDG-PET uptake in regions of the murine aorta exposed to disturbed (inner curvature of arch) or unidirectional flow (outer curvature), however this approach was unsuccessful because PET did not have sufficient spatial resolution to distinguish between these two sites (data not shown). By contrast, modification of carotid arteries with a constrictive cuff (1 mm length) generated distinct flow fields with sufficient spatial separation for PET. Using this approach, we observed that low/oscillatory shear stress enhanced FDG uptake in the arterial wall. We suggest that disturbed flow influences FDG uptake by promoting the recruitment of CD68-positive cells, which were shown by en face staining to accumulate at the low/oscillatory region. Although this concept is consistent with previous observations that macrophages in atherosclerotic lesions display high FDG uptake, 28, 29 we cannot rule out the possible contribution of other cell types. At a broader level, we envisage that molecular imaging of cuffed arteries may be used to assess the influence of biomechanical forces on diverse aspects of vascular physiology including remodeling and plaque progression. 43 Our observation that JNK1 promotes vascular inflammation is consistent with previous reports that JNK isoforms play important roles in cardiovascular injury and disease. Animal studies have revealed that JNK can be activated in arteries in response to injury 44 -46 and during the development of aneurysms 47 or atherosclerotic lesions. 48, 49 Moreover, it was concluded that JNK is involved in the pathophysiology of atherosclerosis because gene transfer of a dominant negative form of JNK1 reduced neointimal formation in injured arteries 44 and genetic deletion of JNK2 reduced foam cell formation and EC dysfunction in hypercholesterolaemia. 49, 50 Thus, we suggest that therapeutic targeting of JNK may reduce vascular inflammation.
In summary, our findings illuminate a novel level of crosstalk between the NF-B and JNK signaling pathways that is regulated by shear stress. This pathway may influence the spatial distribution of atherosclerotic lesions by promoting inflammation at atherosusceptible sites.
